Fundraising Fox

Jay B. Lichter

Investor

Managing Partner at Avalon BioVentures

Rancho Santa Fe, California, United States

FoundedCellular ApproachesCullinan Mica

About

Managing Partner with over 30 years of experience in investing, operations, scientific research, and business development. Led investments in Aratana, Synthorx, Janux, and Nerio, generating over $4B in exits and $800M+ in realized gains. Holds a PhD from the University of Illinois.

Experience

  1. Avalon BioVenturesManaging Partnercurrent2022 β€” present
  2. Arialys TherapeuticsPresident and CEOcurrent2021 β€” presentLa Jolla, CA
  3. Avalon VenturesManaging Directorcurrent2007 β€” present
  4. Avalon VenturesPresident and CEO2006 β€” 2008
  5. Pacific Ridge SchoolTrustee2009 β€” 2016Carlsbad, CA
  6. Aratana Therapeutics IncChairman Of The Board2010 β€” 2015
  7. Afraxis, IncPresident and CEO2008 β€” 2012
  8. ReVision Therapeutics, Inc.President and CEO2010 β€” 2011
  9. CarolusChairman2007 β€” 2009
  10. SyteraCOO2004 β€” 2006
  11. SequenomeVP Business Development2002 β€” 2004
  12. PfizerManager1999 β€” 2000
  13. GensetExecutive Vice President1998 β€” 1999
  14. SequanaDirector1993 β€” 1998
  15. DuPont MerckPost-Doc1992 β€” 1993

Education

  1. University of Illinois ChicagoPh.D, Biochemistry1984 β€” 1990
  2. University of Illinois Urbana-ChampaignBS, Biochemistry1980 β€” 1984

Skills & more

Leadership13Management10Negotiation4Strategic Planning6Strategy8Biotechnology52Lifesciences28Venture Capital38Pharmaceutical Industry29Mergers & Acquisitions34Entrepreneurship32Licensing12
+12 moreBusiness DevelopmentPatentsIntellectual PropertyBusiness StrategyCorporate DevelopmentCommercializationStart-upsInvestmentsDrug DiscoveryInvestor RelationsMergersBiochemistry

From Jay's professional profile.

Same school

Shared employers

Deals Β· 3

Cullinan MicaBoard seat

via Avalon BioVentures Β· filed Mar 2022 Β· $10M raise

Cellular ApproachesBoard seat

via Avalon BioVentures Β· filed Nov 2016 Β· $5.1M raise

AristaMDBoard seat

via Avalon BioVentures Β· filed Mar 2016 Β· $1.4M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Avalon BioVentures